Aβ peptide accumulation is thought to be the primary event in the pathogenesis of Alzheimer's disease (AD), with downstream neurotoxic effects including the hyperphosphorylation of tau protein. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.